These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 27453147)
1. Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory rescheduling. Deacon RM; Nielsen S; Leung S; Rivas G; Cubitt T; Monds LA; Ezard N; Larance B; Lintzeris N Int J Drug Policy; 2016 Oct; 36():104-11. PubMed ID: 27453147 [TBL] [Abstract][Full Text] [Related]
2. Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study. Peacock A; Bruno R; Larance B; Lintzeris N; Nielsen S; Ali R; Dobbins T; Degenhardt L Drug Alcohol Depend; 2016 Sep; 166():125-33. PubMed ID: 27430400 [TBL] [Abstract][Full Text] [Related]
3. Alprazolam use among a sample of Australians who inject drugs: Trends up to six years post regulatory changes. Sutherland R; Peacock A; Nielsen S; Bruno R Int J Drug Policy; 2020 Apr; 79():102721. PubMed ID: 32289592 [TBL] [Abstract][Full Text] [Related]
4. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia. Larney S; Zador D; Sindicich N; Dolan K Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289 [TBL] [Abstract][Full Text] [Related]
5. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence. Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260 [TBL] [Abstract][Full Text] [Related]
6. Interrupted Time Series Analysis of the Effect of Rescheduling Alprazolam in Australia: Taking Control of Prescription Drug Use. Schaffer AL; Buckley NA; Cairns R; Pearson SA JAMA Intern Med; 2016 Aug; 176(8):1223-5. PubMed ID: 27379377 [No Abstract] [Full Text] [Related]
7. Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Stein MD; Kanabar M; Anderson BJ; Lembke A; Bailey GL J Subst Abuse Treat; 2016 Sep; 68():57-61. PubMed ID: 27431047 [TBL] [Abstract][Full Text] [Related]
9. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration. Larney S; Toson B; Burns L; Dolan K Addiction; 2012 Feb; 107(2):372-80. PubMed ID: 21851442 [TBL] [Abstract][Full Text] [Related]
10. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study. Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Addiction; 2016 Feb; 111(2):311-9. PubMed ID: 26451534 [TBL] [Abstract][Full Text] [Related]
11. Risk of fractures requiring hospitalization after an initial prescription for zolpidem, alprazolam, lorazepam, or diazepam in older adults. Finkle WD; Der JS; Greenland S; Adams JL; Ridgeway G; Blaschke T; Wang Z; Dell RM; VanRiper KB J Am Geriatr Soc; 2011 Oct; 59(10):1883-90. PubMed ID: 22091502 [TBL] [Abstract][Full Text] [Related]
12. A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women. Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L Drug Alcohol Rev; 2014 Sep; 33(5):499-505. PubMed ID: 24840554 [TBL] [Abstract][Full Text] [Related]
13. Benzodiazepine and sedative use/abuse by methadone maintenance clients. Iguchi MY; Handelsman L; Bickel WK; Griffiths RR Drug Alcohol Depend; 1993 May; 32(3):257-66. PubMed ID: 8102331 [TBL] [Abstract][Full Text] [Related]
14. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study. Degenhardt L; Larney S; Kimber J; Gisev N; Farrell M; Dobbins T; Weatherburn DJ; Gibson A; Mattick R; Butler T; Burns L Addiction; 2014 Aug; 109(8):1306-17. PubMed ID: 24612249 [TBL] [Abstract][Full Text] [Related]
15. Self-perceived problem with alcohol use among opioid substitution treatment clients. Islam MM; Day CA; Conigrave KM; Topp L Addict Behav; 2013 Apr; 38(4):2018-21. PubMed ID: 23384455 [TBL] [Abstract][Full Text] [Related]
16. Substance use, health status and service utilisation of older clients attending specialist drug and alcohol services. Lintzeris N; Rivas C; Monds LA; Leung S; Withall A; Draper B Drug Alcohol Rev; 2016 Mar; 35(2):223-31. PubMed ID: 26498741 [TBL] [Abstract][Full Text] [Related]
18. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting. Treloar C; Rance J; Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604 [TBL] [Abstract][Full Text] [Related]
19. Alprazolam and wider benzodiazepine misuse in Australia -- sources of supply and evidence of harms. Best D; Wilson A; Reed M; Lloyd B; Eade A; Lubman DI Aust N Z J Psychiatry; 2013 Jan; 47(1):94-5. PubMed ID: 22761394 [No Abstract] [Full Text] [Related]
20. The Impact of Misuse and Diversion of Opioid Substitution Treatment Medicines: Evidence Review and Expert Consensus. Reimer J; Wright N; Somaini L; Roncero C; Maremmani I; McKeganey N; Littlewood R; Krajci P; Alho H; D'Agnone O Eur Addict Res; 2016; 22(2):99-106. PubMed ID: 26426530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]